JPS5564570A - 1*44dihydropridinecarboxylic acid compound - Google Patents

1*44dihydropridinecarboxylic acid compound

Info

Publication number
JPS5564570A
JPS5564570A JP13883579A JP13883579A JPS5564570A JP S5564570 A JPS5564570 A JP S5564570A JP 13883579 A JP13883579 A JP 13883579A JP 13883579 A JP13883579 A JP 13883579A JP S5564570 A JPS5564570 A JP S5564570A
Authority
JP
Japan
Prior art keywords
acid compound
compound
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP13883579A
Other languages
Japanese (ja)
Other versions
JPS6326749B2 (en
Inventor
Behingaa Eguberuto
Bozaato Furiidoritsuhi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of JPS5564570A publication Critical patent/JPS5564570A/en
Publication of JPS6326749B2 publication Critical patent/JPS6326749B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP13883579A 1978-10-31 1979-10-29 1*44dihydropridinecarboxylic acid compound Granted JPS5564570A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782847237 DE2847237A1 (en) 1978-10-31 1978-10-31 Cardiovascular 1,4-di:hydro-pyridine-3-carboxylic acids prodn. - by alkaline hydrolysis of ester(s) with electron withdrawing substit.

Publications (2)

Publication Number Publication Date
JPS5564570A true JPS5564570A (en) 1980-05-15
JPS6326749B2 JPS6326749B2 (en) 1988-05-31

Family

ID=6053511

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13883579A Granted JPS5564570A (en) 1978-10-31 1979-10-29 1*44dihydropridinecarboxylic acid compound

Country Status (2)

Country Link
JP (1) JPS5564570A (en)
DE (1) DE2847237A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5826872A (en) * 1981-07-30 1983-02-17 バイエル・アクチエンゲゼルシヤフト Cardiac contractility enhancer
JPS61161263A (en) * 1985-01-09 1986-07-21 Teijin Ltd Production of 1,4-dihydropyridine monoester monocarboxylic acid
JPS62292757A (en) * 1986-06-12 1987-12-19 Taisho Pharmaceut Co Ltd 1,4-dihydropyridine derivative

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1146866A (en) 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
DK8602336A (en) * 1985-05-21 1986-11-22
US5696139A (en) * 1995-05-12 1997-12-09 Recordati S.A., Chemical And Pharmaceutical Company Use of S-enantiomers of 1,4-dihydropyridine derivatives for treating heart failure
US5912351A (en) * 1995-05-12 1999-06-15 Recordati, S.A. Chemical And Pharmaceutical Company Anhydrous 1,4-Dihydropyridines and salts thereof
EP1123923A4 (en) * 1998-10-23 2002-11-27 Ajinomoto Kk Dihydropyridine derivatives and drug compositions containing the same

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4914614A (en) * 1972-04-18 1974-02-08

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4914614A (en) * 1972-04-18 1974-02-08

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5826872A (en) * 1981-07-30 1983-02-17 バイエル・アクチエンゲゼルシヤフト Cardiac contractility enhancer
JPH066535B2 (en) * 1981-07-30 1994-01-26 バイエル・アクチエンゲゼルシヤフト Cardiac contractility enhancer
JPS61161263A (en) * 1985-01-09 1986-07-21 Teijin Ltd Production of 1,4-dihydropyridine monoester monocarboxylic acid
JPH0455426B2 (en) * 1985-01-09 1992-09-03 Teijin Ltd
JPS62292757A (en) * 1986-06-12 1987-12-19 Taisho Pharmaceut Co Ltd 1,4-dihydropyridine derivative

Also Published As

Publication number Publication date
DE2847237A1 (en) 1980-05-14
JPS6326749B2 (en) 1988-05-31

Similar Documents

Publication Publication Date Title
NZ189530A (en) 2-penem-3-carboxylic acid compounds substituted in the 6 position
JPS54141758A (en) Thioetianic acid derivative
JPS5592393A (en) Aminoorganosiliconacylamino compound
JPS55129279A (en) 2*33dihydrobenzopyrann44carboxyimidates
GB2081715B (en) Novel 5-phenylcarbamoylbarbituric acid compounds
GB2025999B (en) Bistrialkoxysiloxy - silane compound
JPS54135752A (en) Nonatetraene acid derivative
JPS54163582A (en) 22phenoxyy55 trifluoromethypiridine compound
JPS54160397A (en) Antiirhinouiruse compound
JPS54138524A (en) Boronnsilicon compound
JPS54100382A (en) 44pyridonee33carboxylic acid derivative
JPS54145681A (en) 77methoxyy55oxoo5hhthiazolo*2*33b*quinazolinee 22carboxylic acid
JPS54138522A (en) Sulfonateeorganosilanol compound
GB2040919B (en) Epoxysuccinamic acid compounds
JPS5564570A (en) 1*44dihydropridinecarboxylic acid compound
JPS54128538A (en) 44nitroo22trichlormethyllphenyldisulfide compound
JPS54125625A (en) 33hydroxybenzyl compound
JPS54141766A (en) Antiiinflammatory compound
JPS5536471A (en) Spiroketaline compound
JPS54122280A (en) 2*66dimethyll3*55dimethoxycarbonyll44 *00difluoromethoxyphenyl**1*44dihydropyridine
JPS5559193A (en) Bblactam compound
JPS5553271A (en) Novel acylaminoo1*44dihydropyridine compound
JPS554400A (en) Hindereddphenol compound
JPS5553255A (en) 33chlorostiryll2*22dimethyllcyclopropanecarboxylic acid 44fluoroo33phenoxyyalphaa cyanobenzylester
JPS54151989A (en) 44pyrimidylsulfide compound